Radiostics offers subspecialized consulting and image interpretation to clinical research organizations (CROs) conducting industry-sponsored trials with imaging end points. We are leaders in independent radiology review of phase 1 through 4 drug and device trials and work closely with regulatory officials. Our network of independent radiologists and image readers are located across the United States and can provide the services remotely. This allows us to connect you to an experienced group of professionals with the subspecialty expertise to meet the needs of your complex clinical trials.